Efficacy of Ginger (Zingiber officinale) in Ameliorating Chemotherapy-Induced Nausea and Vomiting and Chemotherapy-Related Outcomes: A Systematic Review Update and Meta-Analysis

被引:62
作者
Crichton, Megan [1 ]
Marshall, Skye [1 ]
Marx, Wolfgang [1 ,2 ]
McCarthy, Alexandra L. [3 ,4 ]
Isenring, Elizabeth [1 ,5 ]
机构
[1] Bond Univ, Fac Hlth Sci & Med, 2 Promethean Way, Gold Coast, Qld 4226, Australia
[2] Deakin Univ, Food & Mood Ctr, Impact Strateg Res Ctr, Sch Med,Barwon Hlth, Geelong, Vic, Australia
[3] Univ Auckland, Sch Nursing, Nursing, Auckland, New Zealand
[4] Princess Alexandra Hosp, Div Canc Serv, Woolloongabba, Qld, Australia
[5] Princess Alexandra Hosp, Dept Nutr & Dietet, Woolloongabba, Qld, Australia
关键词
Ginger; Nausea; Emesis; Vomiting; Cancer; DOUBLE-BLIND; CANCER; MALNUTRITION; EXTRACT; PILOT;
D O I
10.1016/j.jand.2019.06.009
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background Ginger has been proposed as an adjuvant treatment for chemotherapy-induced nausea and vomiting. Objective The aim of this systematic review with meta-analyses is to evaluate, in adult cancer patients receiving chemotherapy, the effects of ginger supplementation dose and duration on the incidence, duration, and severity of chemotherapy-induced nausea and vomiting and outcomes related to chemotherapy-induced nausea and vomiting (eg, quality of life and fatigue), compared with placebo or standard antiemetic medication. Method Five electronic databases were searched from database inception to April 2018. The quality of evidence was appraised with the Cochrane Risk of Bias tool and Grading of Recommendations, Assessment, Development, and Evaluation level. Data were pooled using Revman software. Results Eighteen articles were analyzed. The likelihood of acute vomiting was reduced by 60% with ginger supplementation <= 1 g/day for duration >3 days, compared with control groups (odds ratio 0.4, 95% CI 0.17 to 0.81; P=0.01; n=3 studies; n=3 interventions; n=301 participants; I-2=20%; Grading of Recommendations, Assessment, Development, and Evaluation level: Moderate). The likelihood of fatigue was reduced by 80% with ginger supplementation of any dose for duration <3 days (odds ratio 0.2, 95% CI, 0.03 to 0.87; P=0.03; n=1 studies; n=2 interventions; n=219 participants; I-2=0%; Grading of Recommendations, Assessment, Development, and Evaluation level: Low). No statistically significant association was found between ginger and likelihood of overall or delayed vomiting, likelihood or severity of nausea, or other outcomes related to chemotherapy-induced nausea and vomiting. Conclusions Ginger supplementation might benefit chemotherapy-induced vomiting as well as fatigue. Due to clinical heterogeneity, this systematic review update found no association between ginger and chemotherapy-induced nausea and other chemotherapy-induced nausea and vomiting-related outcomes. The results of this systematic review and meta-analysis provide a rationale for further research with stronger study designs, adequate sample sizes, standardized ginger products, and validated outcome measures to confirm efficacy of ginger supplementation and optimal dosing regimens.
引用
收藏
页码:2055 / 2068
页数:14
相关论文
共 46 条
[1]   Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research [J].
Ali, Badreldin H. ;
Blunden, Gerald ;
Tanira, Musbah O. ;
Nemmar, Abderrahim .
FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (02) :409-420
[2]  
Alparslan GB, 2012, J AUST TRADIT-MED SO, V18, P15
[3]  
[Anonymous], 2018, NCCN Clinical Practice Guidelines in Oncology
[4]  
[Anonymous], 2016, Heterogeneity and subgroup analyses in Cochrane Consumers and Communication Group reviews: planning the analysis at protocol stage
[5]  
[Anonymous], 2003, DIET NUTR PREV CHRON
[6]  
[Anonymous], 2014, Review Manager 5 version 5.3
[7]   Oral Intake of Ginger for Chemotherapy-Induced Nausea and Vomiting Among Women With Breast Cancer [J].
Arslan, Muzeyyen ;
Ozdemir, Leyla .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (05) :E92-E97
[8]   Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment [J].
Bloechl-Daum, Brigitte ;
Deuson, Robert R. ;
Mavros, Panagiotis ;
Hansen, Mogens ;
Herrstedt, Jorn .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4472-4478
[9]   A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin [J].
Bossi, P. ;
Cortinovis, D. ;
Fatigoni, S. ;
Rocca, M. Cossu ;
Fabi, A. ;
Seminara, P. ;
Ripamonti, C. ;
Alfieri, S. ;
Granata, R. ;
Bergamini, C. ;
Agustoni, F. ;
Bidoli, P. ;
Nole, F. ;
Pessi, M. A. ;
Macchi, F. ;
Michellini, L. ;
Montanaro, F. ;
Roila, F. .
ANNALS OF ONCOLOGY, 2017, 28 (10) :2547-2551
[10]  
Breen SJ, 2009, MED J AUSTRALIA, V190, pS99